feed,title,long_url,short_url
Benzinga,"Eli Lilly's Alzheimer's Drug, Donanemab Faces FDA's Adcomm Vote Next Week On Data, Risk Profile",https://benzinga.com/general/biotech/24/06/39210889/eli-lillys-alzheimers-drug-donanemab-faces-fdas-adcomm-vote-next-week-on-data-risk-profile,https://da.gd/C6zfZ0
Benzinga,Dolby Laboratories To Acquire GE Licensing In $429M Cash Deal: Strengthens Patent Portfolio,https://benzinga.com/markets/equities/24/06/39210869/dolby-laboratories-to-acquire-ge-licensing-in-429m-cash-deal-strengthens-patent-portfolio,https://da.gd/Fhf81
